Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)
Women should receive counseling aligned with current clinical guidelines. Prior to initiating Testosterone therapy, patients must be informed that its use is off-label. Evidence to date does not support systemic DHEA as an effective treatment for sexual symptoms.
Authors
- Susana Pilnik (ORCID: https://orcid.org/0000-0002-8225-5693)
- Eliana Ojeda (ORCID: https://orcid.org/0000-0001-6606-3029)
- Lucas Bandeira Marchesan (ORCID: https://orcid.org/0000-0003-0687-297X)
- Peter A. Chedraui (ORCID: https://orcid.org/0000-0002-1556-3979)
- Marta Gil-Martín (ORCID: https://orcid.org/0000-0002-8548-5355)
- Alejandra Elizalde Cremonte (ORCID: https://orcid.org/0000-0002-2077-6901)
- Alejandro Manzur
- Alejandra Belardo (ORCID: https://orcid.org/0000-0002-8748-1454)
- Adriana Camero-Lascano
Institutions
- Universidad de La Frontera (CL)
- Universidad de Ciencias Medicas (CR)
- Hospital Italiano de Buenos Aires (AR)
- National University of the Northeast (AR)
- Universidad Espíritu Santo (EC)
- Scripps Clinic Medical Group (US)
- Finis Terrae University (CL)
- Hospital Nossa Senhora da Conceição (BR)
- Universidad Andina del Cusco (PE)
Publication Details
- Journal
- Climacteric
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1080/13697137.2025.2548805
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00